Literature DB >> 23192875

Receptor characterization and susceptibility of cotton rats to avian and 2009 pandemic influenza virus strains.

Jorge C G Blanco1, Lioubov M Pletneva, Hongquan Wan, Yonas Araya, Matthew Angel, Raymonde O Oue, Troy C Sutton, Daniel R Perez.   

Abstract

Animal influenza viruses (AIVs) are a major threat to human health and the source of pandemic influenza. A reliable small-mammal model to study the pathogenesis of infection and for testing vaccines and therapeutics against multiple strains of influenza virus is highly desirable. We show that cotton rats (Sigmodon hispidus) are susceptible to avian and swine influenza viruses. Cotton rats express α2,3-linked sialic acid (SA) and α2,6-linked SA residues in the trachea and α2,6-linked SA residues in the lung parenchyma. Prototypic avian influenza viruses (H3N2, H9N2, and H5N1) and swine-origin 2009 pandemic H1N1 viruses replicated in the nose and in the respiratory tract of cotton rats without prior adaptation and produced strong lung pathology that was characterized by early lung neutrophilia, followed by subsequent pneumonia. Consistent with other natural and animal models of influenza, only the H5N1 virus was lethal for cotton rats. More importantly, we show that the different avian and pandemic H1N1 strains tested are strong activators of the type I interferon (IFN)-inducible MX-1 gene both locally and systemically. Our data indicate that the cotton rat is a suitable small-mammal model to study the infection of animal influenza viruses and for validation of vaccines and therapeutics against these viruses.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23192875      PMCID: PMC3571489          DOI: 10.1128/JVI.00638-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals.

Authors:  M Matrosovich; A Tuzikov; N Bovin; A Gambaryan; A Klimov; M R Castrucci; I Donatelli; Y Kawaoka
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Combination anti-inflammatory and antiviral therapy of influenza in a cotton rat model.

Authors:  Martin Ottolini; Jorge Blanco; David Porter; Lisa Peterson; Spencer Curtis; Gregory Prince
Journal:  Pediatr Pulmonol       Date:  2003-10

Review 3.  Interferon-induced mx proteins: dynamin-like GTPases with antiviral activity.

Authors:  Otto Haller; Georg Kochs
Journal:  Traffic       Date:  2002-10       Impact factor: 6.215

Review 4.  The changing nature of avian influenza A virus (H5N1).

Authors:  Yohei Watanabe; Madiha S Ibrahim; Yasuo Suzuki; Kazuyoshi Ikuta
Journal:  Trends Microbiol       Date:  2011-12-05       Impact factor: 17.079

5.  Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?

Authors:  C Y Cheung; L L M Poon; A S Lau; W Luk; Y L Lau; K F Shortridge; S Gordon; Y Guan; J S M Peiris
Journal:  Lancet       Date:  2002-12-07       Impact factor: 79.321

6.  Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine.

Authors:  Gregory A Prince; Spencer J Curtis; Kevin C Yim; David D Porter
Journal:  J Gen Virol       Date:  2001-12       Impact factor: 3.891

7.  Tumor necrosis factor alpha exerts powerful anti-influenza virus effects in lung epithelial cells.

Authors:  Sang Heui Seo; Robert G Webster
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

8.  Differences between influenza virus receptors on target cells of duck and chicken.

Authors:  A Gambaryan; R Webster; M Matrosovich
Journal:  Arch Virol       Date:  2002-06       Impact factor: 2.574

9.  Differential contribution of PB1-F2 to the virulence of highly pathogenic H5N1 influenza A virus in mammalian and avian species.

Authors:  Mirco Schmolke; Balaji Manicassamy; Lindomar Pena; Troy Sutton; Rong Hai; Zsuzsanna T Varga; Benjamin G Hale; John Steel; Daniel R Pérez; Adolfo García-Sastre
Journal:  PLoS Pathog       Date:  2011-08-11       Impact factor: 6.823

10.  Lack of induction by rhinoviruses of systemic type I interferon production or enhanced MxA protein expression during the common cold.

Authors:  M J Mäkelä; M Halminen; O Ruuskanen; T Puhakka; J Pirhonen; I Julkunen; J Ilonen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-09       Impact factor: 3.267

View more
  25 in total

1.  Efficacy of the Herpes Simplex Virus 2 (HSV-2) Glycoprotein D/AS04 Vaccine against Genital HSV-2 and HSV-1 Infection and Disease in the Cotton Rat Sigmodon hispidus Model.

Authors:  Marina Boukhvalova; Jamall McKay; Aissatou Mbaye; Hannah Sanford-Crane; Jorge C G Blanco; Ashley Huber; Betsy C Herold
Journal:  J Virol       Date:  2015-07-15       Impact factor: 5.103

2.  Modeling Human Respiratory Viral Infections in the Cotton Rat (Sigmodon hispidus).

Authors:  Jorge Cg Blanco; Marina S Boukhvalova; Daniel R Perez; Stefanie N Vogel; Adriana Kajon
Journal:  J Antivir Antiretrovir       Date:  2014-03-03

3.  Inhibition of primary clinical isolates of human parainfluenza virus by DAS181 in cell culture and in a cotton rat model.

Authors:  B G Jones; R T Hayden; J L Hurwitz
Journal:  Antiviral Res       Date:  2013-09-27       Impact factor: 5.970

4.  Syrian Hamster as an Animal Model for the Study of Human Influenza Virus Infection.

Authors:  Kiyoko Iwatsuki-Horimoto; Noriko Nakajima; Yurie Ichiko; Yuko Sakai-Tagawa; Takeshi Noda; Hideki Hasegawa; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

5.  Evaluation of the potential effects of AS03-adjuvanted A(H1N1)pdm09 vaccine administration on the central nervous system of non-primed and A(H1N1)pdm09-primed cotton rats.

Authors:  Camille Planty; Corey P Mallett; Kevin Yim; Jorge C G Blanco; Marina Boukhvalova; Thomas March; Robbert van der Most; Eric Destexhe
Journal:  Hum Vaccin Immunother       Date:  2016-09-14       Impact factor: 3.452

6.  Preparation of quadri-subtype influenza virus-like particles using bovine immunodeficiency virus gag protein.

Authors:  Irina Tretyakova; Rachmat Hidajat; Garrett Hamilton; Noah Horn; Brian Nickols; Raphael O Prather; Terrence M Tumpey; Peter Pushko
Journal:  Virology       Date:  2015-11-02       Impact factor: 3.616

7.  The TLR4 antagonist Eritoran protects mice from lethal influenza infection.

Authors:  Kari Ann Shirey; Wendy Lai; Alison J Scott; Michael Lipsky; Pragnesh Mistry; Lioubov M Pletneva; Christopher L Karp; Jaclyn McAlees; Theresa L Gioannini; Jerrold Weiss; Wilbur H Chen; Robert K Ernst; Daniel P Rossignol; Fabian Gusovsky; Jorge C G Blanco; Stefanie N Vogel
Journal:  Nature       Date:  2013-05-01       Impact factor: 49.962

8.  PROPHYLACTIC ANTIBODY TREATMENT AND INTRAMUSCULAR IMMUNIZATION REDUCE INFECTIOUS HUMAN RHINOVIRUS 16 LOAD IN THE LOWER RESPIRATORY TRACT OF CHALLENGED COTTON RATS.

Authors:  Jorge C G Blanco; Susan Core; Lioubov M Pletneva; Thomas H March; Marina S Boukhvalova; Adriana E Kajon
Journal:  Trials Vaccinol       Date:  2014

Review 9.  Animal models for influenza viruses: implications for universal vaccine development.

Authors:  Irina Margine; Florian Krammer
Journal:  Pathogens       Date:  2014-10-21

10.  N-Glycolylneuraminic Acid in Animal Models for Human Influenza A Virus.

Authors:  Cindy M Spruit; Nikoloz Nemanichvili; Masatoshi Okamatsu; Hiromu Takematsu; Geert-Jan Boons; Robert P de Vries
Journal:  Viruses       Date:  2021-05-01       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.